16,957 Shares in Stevanato Group S.p.A. (NYSE:STVN) Acquired by Bridges Investment Management Inc.

Bridges Investment Management Inc. purchased a new position in shares of Stevanato Group S.p.A. (NYSE:STVN) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,957 shares of the company’s stock, valued at approximately $311,000.

Other large investors also recently bought and sold shares of the company. Hilltop National Bank lifted its stake in shares of Stevanato Group by 34.3% in the 2nd quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock valued at $81,000 after purchasing an additional 1,122 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in Stevanato Group by 54.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock worth $84,000 after buying an additional 1,086 shares during the period. Harbor Capital Advisors Inc. increased its position in shares of Stevanato Group by 109.1% in the second quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock worth $163,000 after acquiring an additional 4,626 shares in the last quarter. Raymond James Trust N.A. raised its stake in shares of Stevanato Group by 18.7% in the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after acquiring an additional 1,613 shares during the period. Finally, Oppenheimer Asset Management Inc. lifted its holdings in shares of Stevanato Group by 59.2% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock valued at $219,000 after acquiring an additional 4,441 shares in the last quarter.

Stevanato Group Stock Performance

Stevanato Group stock opened at €19.26 ($21.40) on Monday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.74 and a quick ratio of 1.13. The firm’s fifty day moving average price is €20.30 and its 200 day moving average price is €22.75. The company has a market capitalization of $5.69 billion, a price-to-earnings ratio of 35.02, a price-to-earnings-growth ratio of 5.50 and a beta of 0.59. Stevanato Group S.p.A. has a 12-month low of €16.56 ($18.40) and a 12-month high of €35.56 ($39.51).

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Tuesday, August 6th. The company reported €0.09 ($0.10) EPS for the quarter, missing the consensus estimate of €0.10 ($0.11) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 10.89% and a net margin of 11.27%. The business had revenue of €259.60 million during the quarter, compared to analyst estimates of €254.92 million. During the same quarter last year, the firm posted $0.15 EPS. The company’s revenue was up 1.7% compared to the same quarter last year. On average, research analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on STVN shares. Morgan Stanley lowered their price target on Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating for the company in a report on Monday, July 15th. Citigroup dropped their target price on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of €29.25 ($32.50).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.